Immunopathogenesis of sjogren's syndrome: “Facts and fancy”

References

• Bloch K J, Buchanan W W, Wohl M J, Bunim J J. Sjogren's syndrome: a clinical, pathological and serological study of sixty-two cases. Medicine 1965; 44: 187–231
   PubMed Web of Science ®Google Scholar
• Moutsopoulos H M, Chused T M, Mann D L, Klippel J H, Fauci A S., et al. Sjogren's syndrome (sicca syndrome): Current issues. Ann Intern Med 1980; 92: 212–226
   PubMed Web of Science ®Google Scholar
• Strand V, Talal N. Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1980; 30: 1046–1052
   Google Scholar
• Fye K H, Terasaki P I, Moutsopoulos H M, Daniels T E, Michalski J P, Talal N. Association of Sjogren's syndrome with HLA-B8. Arthritis Rheum 1976; 19: 883–888
   Google Scholar
• Moutsopoulos H M, Mann D L, Johnson A H, Chused T M. Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979; 301: 761–763
   PubMed Web of Science ®Google Scholar
• Papasteriades C, Skopouli F N, Drosos A A, Andonopoulos A P, Moutsopoulos H M. HLA-alloantigen associations in Greek patients with Sjogren's syndrome. J Autoimmunity 1988; 1: 85–90
   PubMedGoogle Scholar
• Mann D L, Moutsopoulos H M. HLA-DR alloantigens in different subsets of patients with Sjogren's syndrome and in family members. Ann Rheum Dis 1983; 42: 533–537
   PubMed Web of Science ®Google Scholar
• Moriuchi J, Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Sato K, et al. Association between HLA and Sjogren's syndrome in Japanese patients. Arthritis Rheum 1986; 29: 1518–1521
   Google Scholar
• Talal N, Bunim J J. Development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 1964; 36: 529–540
   PubMed Web of Science ®Google Scholar
• Zulman J, Jaffe R, Talal N. Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978; 299: 1215–1220
   PubMed Web of Science ®Google Scholar
• Talal N, Moutsopoulos H M, Kassan S S. Sjogren's syndrome. Clinical and Immunological aspects. Springer-Verlag. 1987
   Google Scholar
• Alspaugh M A, Tan E M. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Arthritis Rheum 1976; 19: 711–719
   PubMed Web of Science ®Google Scholar
• Alspaugh M A, Buchanan W W, Whaley K. Precipitating antibodies to cellular antigens in Sjogren's syndrome, rheumatoid arthritis and other organ and non-organ-specific autoimmune diseases. Ann Rheum Dis 1978; 37: 244–246
   PubMedGoogle Scholar
• Alexander E L, Hirsch T J, Arnett F C, Provost T T, Stevens M B. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjogren's syndrome. J Rheum 1982; 9: 239–246
   PubMed Web of Science ®Google Scholar
• Manoussakis M N, Tzioufas A G, Pange P JE, Moutsopoulos H M. Serological profiles in subgroups of patients with Sjogren's syndrome. Scand J Rheumatol 1986; 61(Suppl.)82–92
   Google Scholar
• Harley J B, Reichlin M, Arnett F C, Alexander E L, Bias W B, Provost T T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 1986; 232: 1145–1147
   PubMed Web of Science ®Google Scholar
• Tzioufas A G, Manoussakis M N, Costello R, Silis M, Papadopoulos N M, Moutsopoulos H M. Cryoglobulins in autoimmune rheumatic diseases: Evidence of circulating monoclonal cryoglobulins in patients with primary Sjogren's syndrome. Arthritis Rheum 1986; 29: 1098–1104
   PubMed Web of Science ®Google Scholar
• Moutsopoulos H M, Steinberg A D, Fauci A S, Lane H C, Papadopoulos N M. High incidence of free monoclonal λ light chains in the sera of patients with Sjogren's syndrome. J IMmunol 1983; 130: 2663–2665
   PubMed Web of Science ®Google Scholar
• Moutsopoulos H M, Costello R, Drosos A A, Mavridis A K, Papadopoulos N M. Demonstration and identification of monoclonal proteins in the urine of patients with Sjogren's syndrome. Ann Rheum Dis 1985; 44: 109–112
   PubMedGoogle Scholar
• Fishleder A, Tubbs R, Hesse B, Levine H. Uniform detection of immunoglobulin gene rearrangements in benign lymphoepithelial lesions. N Engl J Med 1987; 316: 1118–1121
   PubMed Web of Science ®Google Scholar
• Fox R I, Chen P P, Carson D A, Fong S. Expression of a cross reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome. J Immunol 1986; 136: 477–483
   PubMed Web of Science ®Google Scholar
• Fauci A S, Moutsopoulos H M. Polyclonally triggered B-cells in the peripheral blood of normal individuals and in patients with SLE and primary Sjogren's syndrome. Arthritis Rheum 1981; 24: 577–584
   PubMedGoogle Scholar
• Anderson L G, Cummings N A, Asofsky R, Hylton M B, Tarpley T M, Tomasi T B, et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjogren's syndrome. Natural history and response to treatment. Am J Med 1972; 53: 456–463
   PubMed Web of Science ®Google Scholar
• Huang H J, Jones N H, Strominger J L, Herzenberg L A. Molecular cloning of Ly-l, a membrane glycoprotein of mouse T-lymphocytes and a subset of B-cells: molecular homology to its human counterpart Leu-1/T1 (CD5). Proc Nail Acad Sci (USA) 1987; 84: 204–208
   PubMed Web of Science ®Google Scholar
• Mahonar V, Brown E, Leiserson W M, Chused T M. Expression of Lyt-1 by a subset of B-lymphocytes. J Immunol 1982; 129: 532–538
   Google Scholar
• Plater-Zyberk C, Maini R N, Lam K, Kennedy T D, Janossy G. A rheumatoid arthritis B-cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum 1985; 28: 971–976
   PubMed Web of Science ®Google Scholar
• Dauphinee M, Tovar Z, Talal N. B-cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum 1988; 31: 642–647
   PubMed Web of Science ®Google Scholar
• Youinou P, Mackenzie L, Le Massoni G, Papadopoulos N M, Jouquan J, Pennec Y L, et al. CD5-expressing B-lymphocytes in the blood and salivary glands of patients with primary Sjogren's syndrome. J Autoimmunity 1988; 1: 185–194
   PubMed Web of Science ®Google Scholar
• Youinou P, Mackenzie L, Jouquan J, Le Goff P, Lydyard P M. CD5 positive B-cells in patients with rheumatoid arthritis: phorbol ester-mediated enhancement of detection. Ann Rheum Dis 1987; 46: 17–22
   PubMed Web of Science ®Google Scholar
• Stall A M, Farinas C, Tarlinton D M, Herzenberg L A, Strober S. Development of clonal populations of Ly-1 B-cells in (NZB) X (NZW) F1 mice: a murine model of chronic lymphocytic leukemia, Submitted for publication
   Google Scholar
• Wofsky D, Chiang N Y. Proliferation of Ly-1 B-cells in autoimmune NZB and (NZB X NZW) F1 mice. Eur J Immunol 1987; 17: 809–814
   Google Scholar
• Moutsopoulos H M, Fauci A S. Immunoregulation in Sjogren's syndrome. Influence of serum factors on T-cell subpopulations. J Clin Invest 1980; 65: 519–528
   PubMedGoogle Scholar
• Bakhshi A, Miyasaka N, Kavathas P, Daniels T E, Strand C V, Herzenberg L A, Talal N. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter. J Clin Lab Immunol 1983; 10: 63–69
   Google Scholar
• Fox R, Carsten S, Fong S. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjogren's syndrome. Arthritis Rheum 1982; 25: 419–422
   PubMedGoogle Scholar
• Fox R I, Hugli T E, Lanier L L, Morgan E L, Howell F. Salivary gland lymphocytes in primary Sjogren's syndrome lack of lymphocyte subsets defined by Leu-7 and Leu-11 antigens. J Immunol 1985; 135: 207–214
   PubMed Web of Science ®Google Scholar
• Sato K, Miyasaka N, Yamaoka K, Okuda M, Yata J, Nishioka K. Quantitative defect of CD4+ 2H4+ cells in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheum 1987; 30: 1407–1411
   PubMed Web of Science ®Google Scholar
• Miyasaka N, Sauvezie B, Pierce D, Daniels T, Talal N. Decreased autologous mixed lymphocyte reaction in Sjogren's syndrome. J Clin Invest 1979; 66: 928–933
   Google Scholar
• Miyasaka N, Nakamura T, Russell I J, Talal N. Interleukin-2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 31: 109–111
   PubMedGoogle Scholar
• Miyasaka N, Murota N, Yamaoka K, Sato K, Yamada T, Nishido T, Okuda M. Interleukin-2 defect in the peripheral blood and the lung in patients with Sjogren's syndrome. Clin Exp Immunol 1986; 65: 497–505
   PubMed Web of Science ®Google Scholar
• Lindhal G, Hedfors E, Klareskog L, Forsum U. Epithelial HLA-DR expression and T-lymphocyte subsets in salivary glands in Sjogren's syndrome. Clin Exp Immunol 1985; 61: 475–482
   PubMed Web of Science ®Google Scholar
• Moutsopoulos H M, Hooks J J, Chan C C, Dalavanga Y A, Skopouli F N, Detrick B. HLA-DR expression by labial salivary gland tissues in Sjogren's syndrome. Ann Rheum Dis 1986; 45: 677–683
   PubMed Web of Science ®Google Scholar
• Lampson L, Levy R. Two populations of la-like molecules on human B-cell line. J Immunol 1980; 125: 293–299
   PubMedGoogle Scholar
• Yu D, McCune J, Fu K. Two types of la-positive T-cells. J Exp Med 1980; 152: 895–903
   Google Scholar
• Fox R I, Hugli T E, Lanier L L, Morgan E L, Howell F. Salivary gland lymphocytes in primary Sjogren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL-2. J Immunol 1985; 135: 207–214
   PubMed Web of Science ®Google Scholar
• Dalavanga Y A, Drosos A A, Moutsopoulos H M. Labial salivary gland immunopathology in Sjogren's syndrome. Scand J Rheum 1986; 61(Suppl.)67–70
   Google Scholar
• Dalavanga Y A, Detrick B, Hooks J J, Drosos A A, Moutsopoulos H M. Effect of cyclosporine-A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjogren's syndrome. Ann Rheum Dis 1987; 46: 89–92
   Google Scholar
• Miyasaka N, Yamaoka K, Sato K, Kubota T, Okuda M, Nishioka K., et al. An analysis of polyclonal B-cell activation in Sjogren's syndrome: characterization of B-cell lines spontaneously established from the peripheral blood. Scand J Rheum 1986; 61(Suppl.)123–126
   Google Scholar
• Takei M, Dang H, Dauphinee M J, Talal N. Autostimulatory growth factors produced by Sjogren's syndrome B-cell lines, Submitted for publication
   Google Scholar
• Kawamura N, Muraguchi A, Hori A, Horii Y, Mutsuura S, Hardy R R, et al. A case of human B-cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu-1 B-cells. J Clin Invest 1986; 78: 1331–1338
   PubMed Web of Science ®Google Scholar
• Braun J, Citri Y, Baltimore D, Forouzanpour F, King L, Teheranizadeh K, et al. B-Lyl cells: Immortal Ly-1 + B-lymphocyte cell lines spontaneously arising in murine splenic cultures. Immunol Rev 1986; 93: 5–21
   Google Scholar
• Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, et al. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci (USA) 1987; 84: 228–231
   PubMed Web of Science ®Google Scholar
• Gurney M E, Heinrich S P, Lee M R, Yin H. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 1986; 234: 566–574
   PubMed Web of Science ®Google Scholar
• Condere L J, D'Agay M F, Danon F, Harzie M, Brocherion C, Clauvel J P. Sicca complex and infection with human immunodeficiency virus. Arch Intern Med 1987; 147: 898–901
   Google Scholar